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THE HISTORY OF THE DEVELOPMENT OF
NARCOTICS
NATHAN B. EDDY*
Man and animals generally seek escape from discomfort. Man today seems
more prone to do so than ever before and, as will be seen, has acquired a consider-
able variety of means to that end. No one knows when man learned that there
were natural agents available, the poppy among them, to ease his pains; but he did
acquire that knowledge, and there the history of narcotics begins. Legally and
otherwise, narcotic has a broader connotation than opiate. Practically, however,
the major part of the narcotics problem centers around the opiates and their synthetic
substitutes, and this account of historical development will deal with these only.
Chopra suggests that the food value of the seeds of the opium poppy was recog-
nized much earlier than the somniferous property of the capsule or poppy head,"
but the capsules were used in the preparation of soporific drugs and soothing bever-
ages from time immemorial. Poppies were grown for the capsules in Asia Minor
many centuries ago, and the Arabs carried the dried poppy heads to eastern countries
at a very early date. Eventually, someone discovered that at one stage in the develop-
ment of the poppy plant, Nature seemed to concentrate its soporific properties-that
is, the ingredients responsible for them-in the plant juice which would exude from
the lanced ripe poppy head. This juice, collected and dried, is crude opium.
Opium became a household remedy and the mainstay of the physician in its
crude form, in pills, and in various liquid preparations-laudanum, paregoric, etc.-
whatever the symptomatic need. It also became a medium of social exchange and
self indulgence as a confection and, in modified form, for smoking. Even into the
latter half of the nineteenth century, there was little recognition of and less attention
paid to overindulgence in or abuse of opium. It was the panacea for all ills. When
a person became tolerant to its action and dependent upon it so that abstinence
symptoms developed if a dose or two were missed, more was taken for the aches
and pains and other discomforts of abstinence, just as it was taken for similar
symptoms from any other cause.
In the first decade of the last century, just about 15o years ago, the curiosity of
Sertiirner, a German pharmacist, brought about the separation and recognition of
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the main ingredient of opium Sertiirner called the agent morphine; but, although
it was admittedly the most important active constituent of opium, physicians were
slow to use it in preference to the crude drug, and there were many assertions of the
superiority of the latter, even after the discovery of the hypodermic syringe towards
the middle of the century.
Codeine, another of the natural alkaloids of opium, was isolated only a few years
after the discovery of morphine. It was tried almost immediately in clinical medi-
cine3 but gained little popularity for about another fifty years. The first artificially
produced derivative of morphine appears to have been apomorphine; 4 ethylmorphine
(dionin) was reported in i88;' and in 189o, Dott and Stockman described a series
of morphine derivatives and discussed at length the modifications of action pro-
duced by changes in chemical structure.'
Up to this time, the principal objective of work in this field was elucidation of
the structure of morphine. Attention, however, began to be focused on improve-
ment in therapeutic effectiveness when diacetylmorphine (heroin) was introduced
in I898.7 The frequent abuse of morphine and the phenomena of addiction had
begun to be recognized, and heroin was hailed as a drug of increased effectiveness
with decreased addiction liability. This was the first of a series of such claims for
new agents arising from overenthusiastic misinterpretation of inadequate data,
usually advanced in spite of warnings of danger. Even the early literature on
heroin contains such warnings. Strube, for example, noted that his patients liked the
new drug and continued to take the heroin pills after he ceased to prescribe them;
he admitted the possibility of addiction.' Nevertheless, heroin gained rapidly in
popularity, became eventually the drug of choice in the illicit drug traffic, and, in
some quarters, still is considered indispensable.
The next thirty years saw much work on the morphine structure, intensive in-
vestigation of the details of morphine action in the body, but introduction of com-
paratively few new morphine derivatives. Worth mentioning, however, are di-
hydrocodeine, dihydromorphine, dihydrocodeinone (dicodid, Hycodan), dihydro-
morphinone (Dilaudid), and dihydrohydroxycodeinone (eukodal), all of which
were tried in Germany during this period. Dilaudid was introduced in this country
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in 1932; the use of dicodid for cough began some years later; and interest in dihydro-
codeine is currently being revived.
Beginning in 1929 and continuing for about eleven years, the Drug Addiction
Committee of the National Research Council directed a comprehensive program
of chemical, pharmacological, and clinical investigations, which included the pro-
duction and testing of about 150 morphine derivatives and twice that number of
compounds synthesized from simpler chemical structures. The program had two
major accomplishments to its credit: the proof, by accumulation of systematic data,
that chemical modification of morphine is not always followed by uniform modifica-
tion of all of its many effects on the animal body; and the demonstration of sig-
nificant analgesic (pain-relieving) action with simpler chemical substances not
closely related to the structure of morphine. Two of the new morphine derivatives
assumed practical importance and were introduced to physicians generally. One of
these, metopon, had increased analgesic power, especially when taken by mouth, with
less of the dulling effect which morphine has on the senses generally. The other,
desomorphine, had greatly increased analgesic power of short duration, with little
or no tendency to produce nausea or vomiting so commonly seen when morphine
is used. None of the many synthetic substances investigated merited extensive
clinical trial, and no morphine-like analgesic without addiction liability was found.
In the late x93o's, German chemists were looking for a synthetic substitute for
atropine. One product of this research was shown to have significant analgesic
effect and, subsequently, other morphine-like properties; this was meperidine (pethi-
dine, Demoral, Dolantin, etc.)Y Thus, a by-product of one investigation became
the first wholly synthetic pain-relieving drug with an activity comparable practically
to that of morphine. At first sight, meperidine appeared to bear no relation to the
chemical structure of morphine, in spite of similarities of action. After the fact-i.e.,
after the demonstration of its analgesic effect-however, Schaumann quite ingeni-
ously showed that there were, indeed, chemical features common to the structures of
both compounds.
Recognition of the morphine-like characteristics of meperidine, caused it to be
brought almost immediately under narcotics control in Germany. At that time, in
this country, however, there were no means for bringing about such control of a
substance not derived from the natural sources specifically named in the narcotics
law, and this lack was corrected only by the enactment of a special statute on July i,
t944.10 Meanwhile, although tests at the Public Health Service Addiction Research
Center had demonstrated its addiction potentiality,1 ' the impression was fostered
that meperidine was relatively safe in this respect. Unfortunately, this false im-
pression persists, and persons have become addicted to meperidine who might have
escaped if there had been an understanding of the risk involved. Rasor and Crecraft
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reported the admission to the Public Health Service Hospital at Lexington of 457
meperidine addicts in a thirty-eight-month period to September 1, 1954.12 Nearly
half of them were members of the medical or ancillary professions, who, for the most
part, admitted that they turned to this drug because they thought it less likely to
produce addiction. Confirmed addicts, too, turn to meperidine when it is available;
thirty-seven per cent of Rasor's cases had been addicted to other narcotics first.
Meperidine is not readily available through illegal sources, but physicians seem less
loathe to prescribe it than other narcotics-most probably owing to the impression
of relative safety already commented on. The majority of meperidine addicts ad-
mitted to Lexington stated that physicians were their source of supply.
Meperidine production in this country was 123,362 ounces in 1946, 251,oo9 ounces
in 1952, and 394,048 ounces in 1955. Of the last amount, 329,348 ounces were for
domestic use, 20,108 ounces for export. Morphine production was about iooooo
ounces in 1946 and was 49,062 ounces in 1955. Again, these figures seem to reflect
the greater readiness of physicians to prescribe meperidine, because if one were to
assume that all of the decrease in morphine production was replaced by meperidine,
the amount required for such replacement should be only about 250,000 ounces, the
dose ratio between the two drugs being of the order of 1:5"
The discovery of meperidine had a greater effect on the over-all narcotic picture
than its replacement or potential replacement of morphine. As a replacement, it
still has the disadvantages of the latter, but the degree of success as a morphine
substitute which it represented had a tremendously stimulating effect on the work
of organic chemists in this field. The original German investigators and others
there, in England, and in America made many meperidine derivatives, striving, as
had been done in the program of the Drug Addiction Committee, to dissociate by
chemical modification the features responsible for pain relief from those which
produced undesirable side-effects and addiction. A few of these modifications came
to clinical trial and some to considerable medical use. Alphaprodine, for example,
is reported to be a very useful adjunct to nitrous oxide anesthesia. Ketobemidone
is a very powerful pain-relieving drug but develops an intense physical dependence
(addiction) with great rapidity; its addiction liability has deterred manufacturers
from developing it in this country and has led to a recommendation that its medical
use be abolished entirely.
German chemists again achieved an outstanding success in the 194o's by the
synthesis of methadone, qualitatively morphine-like in nearly all respects in animals
and man and quantitatively equivalent to morphine as a pain-relieving drug, milligram
for milligram.'3 Again, methadone seemed very unlike morphine (or meperidine) in
12 Rasor and Crecraft, Addiction to Meperidine Hydrochloride (Demerol Hydrochloride), 157
A. M. A. J. 654 (1955).
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structure; but again, close scrutiny revealed that there were structural characteristics
common to all three. Methadone very easily substituted for morphine in an estab-
lished addiction, readily produced tolerance and addiction when administered alone,
but differed significantly from morphine in the abstinence syndrome which followed
abrupt withdrawal of the drug. The methadone abstinence syndrome was slower in
onset (two to three days as compared with about twelve hours after morphine), less
intense, and much more prolonged.
Methadone is so morphine-like in all of its pharmacological characteristics that
it could undoubtedly be used in place of morphine in general medical practice. The
only advantage of such use, however, would seem to be the relatively mild, prolonged
abstinence syndrome, making withdrawal of the drug easier should addiction develop.
A recent report compared more than 200 methadone derivatives with respect
to the effect of chemical modifications on analgesic effectiveness.' 4 Only a few of
these have been tried in man, and none has yet come into general use. Work on
this group of compounds continues, however, and currently two members of the
series give some promise of clinical usefulness.
Through the years, chemists came to a very complete understanding of the
chemical constitution of morphine but attained its total synthesis only quite recently.' 5
This is an outstanding scientific achievement, but for the greatest analgesic
effectiveness, complete synthesis is not necessary. In 1947, Grewe had already
synthesized N-methylmorphinan, representing the basic ring structure of morphine,
but without all of its peripheral groups;' 6 and in 1949, Schnider and Griissner moved
a step closer to morphine by the preparation of 3-hydroxy-N-methylmorphiman
(racemorphan, Dromoran).17 They also made the methyl ether-that is, the codeine
analog (racemethorphan)-in this new series. Racemorphan is a more powerful
analgesic than morphine, with at least as long a duration of action. Like morphine,
it is addicting; and like morphine, it is prone to produce the same side-effects, but
perhaps somewhat less frequently. Racemorphan and racemethorphan are mixtures
of optical isomers, and it has been proven that analgesic action and addiction are
produced by one of these isomers only. Most interestingly, the nonaddicting isomer
(dextromethorphan) of the codeine analog has been shown to be an effective agent
for the relief of cough and is marketed for that purpose.
The chemists have not nearly exhausted the possibilities in any one of the
groups of analgesic compounds which have been mentioned-modifications of mor-
phine, meperidine, methadone, or morphinan structures. They have, nevertheless,
branched out in other directions and synthesized entirely new structures which have
proved to be as potent as morphine in pain-relieving power, at least experimentally-
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dithienylbutenylamines, hexamethyleneimines, and phenylcyclohexanes, for example,
to name only three new types. Unfortunately, when significant analgesic action
appears, the ability to produce addiction is also demonstrable. There is one important
exception which may, however, be the clue to a solution of the problem, analgesic
action without addiction liability, which is the basis for all of the work on new
analgesic agents.
A feature of the morphine structure is the occurrence in the molecule of an
heterocyclic nitrogen carrying a methyl group, long believed to be optimal for
analgesic action. Forty years ago, Pohl substituted allyl for this methyl group in
codeine and reported that the resulting compound was to some extent antagonistic to
morphine.' In i942, Weijlard and Erickson succeeded in making a similar sub-
stitution in morphine. 9 This is the compound now known as nalorphine (Nalline).
It is strongly antagonistic to many of the effects of morphine in suitable concentra-
tion; it will not satisfy a morphine addiction nor produce physical dependence when
repeatedly administered. Its antagonistic effect is demonstrated strikingly by the
removal of the respiratory depression produced by overdoses of morphine and mor-
phine-like substances and by the precipitation of a typical abstinence syndrome if it
is given to a morphine addict.
In the laboratory, nalorphine exhibits little analgesic action. It can be given to
man in combination with morphine, at least in certain dose ratios, without inter-
fering materially with morphine's analgesic effect. Most recently, it has been reported
that nalorphine given alone to patients in pain is as effective as morphine in re-
lieving that pain2 Here, then, is one instance in which analgesia equivalent to
that of morphine can be produced by a compound which is not addicting. Nal-
orphine is not a practical analgesic or a practical solution of the addiction problem
because of the occurrence of quite remarkable side-effects, worse if the individual has
received recently a dose of morphine. Perhaps, however, it is not too much to expect
that a nalorphine-like compound will be found without its disagreeable side-effects,
a useful nonaddicting analgesic.
In conclusion, we can agree with opinion expressed by the Drug Addiction Com-
mittee of the National Research Council that "all needs for morphine and related
substances for symptomatic relief can be met by synthetics now known."'" This
does not say that synthetics are superior to the natural alkaloids, though some may
be. We have reached the point where we could make out with the synthetics in
clinical practice if the need arose, and we may be on the brink of a practical
analgesic without addiction liability.
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